The orders are shipped to almost all countries of the world, for the exception of some countries in Asia.
Anti Bacterial / Generic Flagyl
Package
Price
Per Pill
Order
250mg × 30 pills
$49.95
US $ 1.67
250mg × 60 pills
$69.95
US $ 1.17
250mg × 90 pills
$79.95
US $ 0.89
Most popular quantity.
What is metronidazole?
Metronidazole is an antibiotic. It fights bacteria in your body.
Metronidazole is used to treat infections such as abdominal infections, skin and tissue infections, bone and joint infections, gynecologic infections, and respiratory tract infections.
Metronidazole may also be used for purposes other than those listed in this medication guide.
What is the most important information I should know about metronidazole?
Take all of the metronidazole that has been prescribed for you even if you begin to feel better. Your symptoms may start to improve before the infection is completely treated.
Do not drink alcohol while taking metronidazole. Flushing, fast heartbeats, nausea, and vomiting may occur when alcohol is ingested during metronidazole therapy.
What should I discuss with my doctor before taking metronidazole?
Before taking this medication, tell your doctor if you have
liver disease,
a stomach or intestinal disease, or
epilepsy or another seizure disorder.
You may not be able to take metronidazole, or you may require a lower dose or special monitoring during your therapy if you have any of these conditions.
Metronidazole is in the FDA pregnancy category B. This means that it is not likely to harm an unborn baby. Do not, however, take metronidazole without first talking to your doctor if you are pregnant.
Metronidazole passes into breast milk and may affect a nursing infant. Do not take this medication without first talking to your doctor if you are breast-feeding a baby.
How should I take metronidazole?
Take metronidazole exactly as directed by your doctor. If you do not understand these instructions, ask your pharmacist, nurse, or doctor to explain them to you.
Take each dose with a full glass (8 ounces) of water.
Take all of the metronidazole that has been prescribed for you even if you begin to feel better. Your symptoms may start to improve before the infection is completely treated.
Store metronidazole at room temperature away from moisture and heat.
Use injectable metronidazole exactly as directed by your doctor. If you do not understand the instructions, ask your pharmacist, nurse, or doctor to explain them to you.
What happens if I miss a dose?
Take the missed dose as soon as you remember. Take the rest of the day's doses at evenly spaced intervals unless otherwise directed by your doctor.
What happens if I overdose?
Seek emergency medical attention.
Symptoms of a metronidazole overdose include nausea, vomiting, dizziness, loss of coordination, numbness and tingling, and seizures.
What should I avoid while taking metronidazole?
Do not drink alcohol while taking metronidazole. Flushing, fast heartbeats, nausea, and vomiting may occur when alcohol is ingested during metronidazole therapy.
Be aware of the alcohol content of other products such as cough and cold medicines. Alcohol in these products can also cause a reaction.
What are the possible side effects of metronidazole?
If you experience any of the following serious side effects, stop taking metronidazole and seek emergency medical attention:
an allergic reaction (swelling of your lips, tongue, or face; shortness of breath; closing of your throat; or hives);
seizures;
numbness or tingling;
dizziness or loss of coordination; or
severe diarrhea.
Other, less serious side effects may be more likely to occur. Continue to take metronidazole and talk to your doctor if you experience
darkening of your urine;
nausea, vomiting, or loss of appetite;
an unpleasant metallic taste in your mouth;
constipation or mild diarrhea;
headache; or
swollen or sore tongue.
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.
What drug(s) may interact with metronidazole?
alcohol or alcohol-containing beverages or medicines
amprenavir
barbiturate medicines for inducing sleep or treating seizures (convulsions)
carbamazepine
cimetidine
disulfiram
fluorouracil
lithium
methadone
phenytoin
ramelteon
sirolimus
tacrolimus
warfarin
What is the shelf life of the pills?
The expiry date is mentioned on each blister. It is different for different batches. The shelf life is 2 years from the date of manufacture and would differ from batch to batch depending on when they were manufactured.
I appreciate your personalized customer service and prompt follow up. All I can say is this, if you are this straight forward and direct when something goes wrong, then you treat your customers with respect. And if you do that on a regular basis, you deserve to have great things happen to you in the future.
I will be in touch.
Thanks.
Biovail Comments On Filing Of Lawsuit
Biovail Corporation (NYSE, TSX: BVF) today announced that it has been notified that a proposed securities class action lawsuit has been filed in the U.S. District Court Southern District of New York against the Company, its Chairman and two former officers. The complaint has been filed on behalf of all persons and entities that purchased Biovail securities from December 14, 2006 through July 19, 2007.
Phase III Study Showed Rituxan In Combination With Chemotherapy Improved Progression-Free Survival In Patients With Relapsed Chronic Leukemia
Genentech, Inc. (NYSE: DNA) and Biogen Idec (Nasdaq: BIIB) today announced that a global Phase III study of Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide chemotherapy met its primary endpoint of improving progression-free survival (PFS), as assessed by investigators, in patients with previously treated CD20-positive chronic lymphocytic leukemia (CLL) compared to chemotherapy alone. There were no new or unexpected safety signals reported in the study.
FDA Continues Review Of Takeda's New Drug Application For Alogliptin (SYR-322), A DPP-4 Agent For Type 2 Diabetes
Takeda Pharmaceutical Company Limited ("Takeda") announced that Takeda Global Research and Development Center, Inc., a wholly owned United States (U.S.) subsidiary, received notification that the U.S. Food and Drug Administration (FDA) will not be able to complete its review of the alogliptin New Drug Application (NDA) by the Prescription Drug User Fee Act (PDUFA) date of October 27, 2008.